Inflammation reduction

Reducing inflammation with Hyperbaric Oxygen Therapy

Numerous studies report chronic inflammation as an important factor in these diseases and conditions:

Alzheimer’s
Atherosclerosis
Autism Spectrum Disorder
Cancer
Stroke
Diabetes
Traumatic Brain Injury

Hyperbaric oxygen therapy (HBOT) has been demonstrated to substantially attenuate inflammation throughout the body. HBOT drives increased levels of oxygen into the body, which travels through the plasma, subsequently reducing inflammation and pain. Studies have shown that HBOT increases anti-inflammatory levels and provides increased cellular aid to heal target regions. As oxygen serves as one of the primary mechanisms to ameliorating inflammation, HBOT creates the environment where this process is stimulated and enhanced.

Studies have shown that hyperbaric oxygen therapy is an effective treatment for reducing inflammation in the following ways:

SUPPORT ANTI-INFLAMMATORY PROCESS AT THE CELLULAR LEVEL

Decreases Acute/Chronic Inflammation • Minimizes Pain & Discomfort
Increases Anti-Inflammatory Cytokines • Reduces Swelling
Induces Fibroblast Activation

REDUCE NEUROINFLAMMATION

Ameliorates Autism Symptoms
Supports the Prevention & Treatment of Stroke
Reduces Risk of Alzheimer’s & Parkinson’s Disease

DECREASE GASTROINTESTINAL INFLAMMATION

Remediates Inflammatory Bowel Disease
Ameliorates Ulcerative Colitis
Improves Nutritional Absorption

RELIEVE SOFT TISSUE/JOINT INFLAMMATION

Remediates Osteoarthritis & Rheumatoid Arthritis
Ameliorates Tendinitis
Accelerates Recovery from Sports-Related & High-Impact Injuries

PREVENT THE ONSET OF CHRONIC INFLAMMATORY-RELATED DISEASES

Attenuates Cancer Risk & Progression
Reduces Risk of Atherosclerosis, Heart Attack & Stroke
Ameliorates Diabetic Conditions Linked to Inflammation

ADDITIONAL SUPPORT FOR INCREASING LONGEVITY AND THE ONSET OF CHRONIC INFLAMMATORY-RELATED DISEASES

Inflammation is a factor that is common to many age-related conditions and diseases. Additionally, those who are interested in longevity (life extension) and bio-hacking are also interested in therapies that reduce inflammation.

Research

A study published in 2007 examined the effects of HBOT for atherosclerosis (plaques of fatty material that line the walls of arteries) with mice. Two groups of mice were treated with either 5 or 10 weeks of HBOT, whereas two other groups remained untreated and were used as a control group. After the introduction of low-density lipoprotein, the treated group exhibited positive changes in the immune/inflammatory response. This represents a critical component of the beneficial effects of HBOT. This study demonstrated that HBOT significantly reduced the circulating levels of low-density lipoprotein that can cause heart disease, kidney disease, and stroke. Additionally, HBOT resulted in a substantial attenuation in the production of pro-inflammatory cytokines in response to an inflammatory stimulus and showed a marked increase in the production of anti-inflammatory cytokine Interleukin 10 by spleen cells. The observed improvements were already noted after only 5 weeks of treatment.

Clinical Research

The following research highlights the benefit of hyperbaric oxygen therapy and inflammation reduction.

Study